Dr. Jorge J Castillo, MD
Claim this profileDana Farber Cancer Institute
Studies Waldenstrom's Macroglobulinemia
Studies Waldenstrom Macroglobulinemia
4 reported clinical trials
6 drugs studied
Area of expertise
1Waldenstrom's Macroglobulinemia
MYD88 positive
MYD88 negative
MYD88
2Waldenstrom Macroglobulinemia
MYD88 positive
MYD88 negative
MYD88
Affiliated Hospitals
Clinical Trials Jorge J Castillo, MD is currently running
Acalabrutinib + Rituximab
for Peripheral Neuropathy
In this research study, is combining a new treatment acalabrutinib with a standard treatment, rituximab or other CD20 antibody, to determine whether this combination is safe and effective for participants with Immunoglobulin (Ig) M monoclonal gammopathy of undetermined significance ( IgM MGUS) or Waldenström macroglobulinemia WM related neuropathies. The names of the study drugs involved in this study are/is: * Acalabrutinib * Rituximab or similar CD20 antibody
Recruiting1 award Phase 28 criteria
Pirtobrutinib + Venetoclax
for Waldenström Macroglobulinemia
This trial is testing the safety and effectiveness of two drugs, pirtobrutinib and venetoclax, in patients with Waldenström Macroglobulinemia (WM) who have already been treated but still have symptoms. Pirtobrutinib blocks a protein that helps cancer cells grow, while venetoclax blocks a protein that helps them survive. The goal is to see if this combination can better control the disease.
Recruiting1 award Phase 213 criteria
More about Jorge J Castillo, MD
Clinical Trial Related3 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Jorge J Castillo, MD has experience with
- Venetoclax
- Ibrutinib
- Acalabrutinib
- Rituximab
- Pirtobrutinib
- Dasatinib
Breakdown of trials Jorge J Castillo, MD has run
Waldenstrom's Macroglobulinemia
Waldenstrom Macroglobulinemia
MYD88 Gene Mutation
Peripheral Neuropathy
Monoclonal Gammopathy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jorge J Castillo, MD specialize in?
Jorge J Castillo, MD focuses on Waldenstrom's Macroglobulinemia and Waldenstrom Macroglobulinemia. In particular, much of their work with Waldenstrom's Macroglobulinemia has involved MYD88 positive patients, or patients who are MYD88 negative.
Is Jorge J Castillo, MD currently recruiting for clinical trials?
Yes, Jorge J Castillo, MD is currently recruiting for 2 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Jorge J Castillo, MD has studied deeply?
Yes, Jorge J Castillo, MD has studied treatments such as Venetoclax, Ibrutinib, Acalabrutinib.
What is the best way to schedule an appointment with Jorge J Castillo, MD?
Apply for one of the trials that Jorge J Castillo, MD is conducting.
What is the office address of Jorge J Castillo, MD?
The office of Jorge J Castillo, MD is located at: Dana Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.